Tafluprost price?

Understanding Tafluprost Pricing

Tafluprost, an analogue of prostaglandin, is used to treat glaucoma and ocular hypertension. As a relatively recent medication, its price can vary depending on several factors.

Global Availability

Tafluprost is sold under various brand names, such as Tasima in the United States. The medication is available in some European countries, but its global availability is limited due to patent protection. According to DrugPatentWatch.com [1], Tafluprost's patent expires in 2025, which may lead to the emergence of generic versions.

Current Prices

On the U.S. market, prices for Tafluprost eye drops vary between pharmacies. A one-month supply of the medication can cost anywhere from $400 to $800, depending on the pharmacy and location. Prices may also depend on the concentration of the solution (e.g., 0.00125% or 0.002%) and the packaging.

Comparison to Other Glaucoma Medications

Other glaucoma medications, such as prostaglandin analogues (e.g., Xalatan, Lumigan), can be more expensive than Tafluprost. However, prices can fluctuate over time, and prices for other medications may be affected by patent expirations and generic competition.

Future Pricing Prospects

As Tafluprost's patent expires, we can expect prices to decrease due to generic competition. According to MarketWatch [2], prices for glaucoma medications can drop by as much as 50% after patent expiration.

Regulatory Considerations

The price of Tafluprost may be influenced by regulatory factors, such as Medicaid and Medicare reimbursement rates. In the United States, the Centers for Medicare and Medicaid Services (CMS) sets reimbursement rates for medications covered by these programs.

Sources:

[1] DrugPatentWatch.com. Tafluprost. https://www.drugpatentwatch.com/drug/tafluprost

[2] MarketWatch. Glaucoma medication prices drop after patent expiration. https://www.marketwatch.com/story/glaucoma-medication-prices-drop-after-patent-expiration-2022-02-01